Question follow-through · 12109
Information Commissioner's Office: Public Appointments
To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the adequacy of the appointments process undertaken for the new Information Commission Board.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department for Science, Innovation and Technology
- Tabled
- 23 Jun 2026
- Target answer date
- 25 Jun 2026
- Answer
- 1 Jul 2026 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Recorded timeline
23 Jun 2026
Question tabled
To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the adequacy of the appointments process undertaken for the new Information Commission Board.
25 Jun 2026
Target answer date
Date supplied by the official written-questions record.
1 Jul 2026
Answer published
We are confident in the adequacy of the process that was followed to appoint non-executive members to the new Information Commission. The recruitment campaign was launched last June and has concluded. It was carried out in accordance with the public appoi...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Innovation and Technology: Obesity
2 Jul 2026 · To ask the Secretary of State for Science, Innovation and Technology, what funding has been allocated within the Obesity Pathway Innovation Programme to assess the outcomes of that programme.
Innovation and Technology: Obesity
14 Jul 2026 · To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 13 July 2026 to Question 15321 on Innovation and Technology: Obesity, whether the evaluation activity will be independent of Eli Lilly and Company; whether it